- >
- News & Events
- >
- Press Releases
Press Releases
Page 1 of 29
Onxeo: Report on the Combined General Meeting of June 10, 2021
All resolutions voted in accordance with Board of Directors’ recommendations Shefali Agarwal, MD, a clinical development expert in oncology, is […]
06/10/2021
Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States
This new patent protects both AsiDNA™ in combination with a PARP inhibitor and the use of the combination for the […]
06/09/2021
Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts
This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the development of […]
05/31/2021
Onxeo’s Combined General Meeting on June 10, 2021 in camera: availability of preparatory documents and live webcast login information
Paris (France), May 21, 2021 – 5:45 p.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]
05/21/2021
Publication of the 2020 Annual Financial Report
Paris (France), April 23, 2021 – 7.00 pm CEST – Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: […]
Tags: Financials & Corporate
04/23/2021
Onxeo Reports Full-Year 2020 Financial Results and Provides Business Update
Several major clinical milestones achieved in 2020 by AsiDNA™, including promising initial results in combination with chemotherapy and the launch […]
04/21/2021
Onxeo announces the success of its Rights Issue with €9.7 million raised
This transaction will accelerate the development of the Company and its portfolio and extend its financial horizon to the end […]
04/12/2021
Onxeo to Present New Preclinical Data at AACR 2021
Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation of PARP interfering cancer drug […]
04/08/2021
Onxeo will publish its annual results on April 21, 2021
The Annual General Meeting will be held on June 10, 2021 Paris (France), March 24, 2021 – 6 pm CET […]
Tags: Financials & Corporate
03/24/2021
Page 1 of 29